# Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

- Source: PR Newswire M&A
- Published: 2026-10-30T00:15:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/bambusa-therapeutics-announces-pricing-of-upsized-initial-public-offering-302924376.html
- Canonical: https://groundlevelnews.com/story/bambusa-therapeutics-announces-pricing-of-upsized-initial-public-offer-4dbbae/

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, today announced the...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._